Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

168 8 Interleukin-10 in Cancer Immunity
References
1 Spits H, de Waal Malefyt R. Functional
characterization of human IL-10.
Int Arch Allergy Immunol 1992; 99:8±
15.
2 Fiorentino DF, Bond MW, Mosmann
TR. Two types of mouse T helper cell.
IV. T h2 clones secrete a factor that inhibits
cytokine production by Th1 clones.
J Exp Med 1989; 170: 2081±95.
3 Kim JM, Brannan CI, Copeland NG,
Jenkins NA, Khan TA, Moore KW.
Structure of the mouse IL-10 gene and
chromosomal localization of the mouse
and human genes. J Immunol 1992;
148: 3618±23.
4 Zdanov A, Schalk-Hihi C, Gustchina
A, Tsang M,Weatherbee J,
Wlodawer A. Crystal structure of interleukin-10
reveals the functional dimer
with an unexpected topological similarity
to interferon g. Structure 1995; 3:
591±601.
5 Walter MR, Nagabhushan TL. Crystal
structure of interleukin 10 reveals an
interferon g-like fold. Biochemistry
1995; 34: 12118±25.
6 Zdanov A, Schalk-Hihi C, Wlodawer
A. Crystal structure of human
interleukin-10 at 1.6 A resolution and a
model of a complex with its soluble receptor.
Protein Sci 1996; 5: 1955±62.
7 Josephson K, Logsdon NJ,Walter MR.
Crystal structure of the IL-10/IL-10R1
complex reveals a shared receptor binding
site. Immunity 2001; 15: 35±46.
8 Ealick SE, Cook WJ,Vijay-Kumar S,
et al. Three-dimensional structure of recombinant
human interferon-g. Science
1991; 252: 698±702.
9 Ajuebor MN, Das AM,Virag L,
Flower RJ, Szabo C, Perretti M. Role
of resident peritoneal macrophages and
mast cells in chemokine production
and neutrophil migration in acute inflammation:
evidence for an inhibitory
loop involving endogenous IL-10. JImmunol
1999; 162: 1685±91.
10 Asseman C, Mauze S, Leach MW,
Coffman RL, Powrie F. An essential
role for interleukin 10 in the function
of regulatory T cells that inhibit intest-
inal inflammation. J Exp Med 1999;
190: 995±1004.
11 Huhn RD, Radwanski E, O'Connell
SM, et al. Pharmacokinetics and immunomodulatory
properties of intravenously
administered recombinant human
interleukin-10 in healthy volunteers.
Blood 1996; 87: 699±705.
12 Ho AS, Liu Y, Khan TA, Hsu DH, Bazan
JF, Moore KW. A receptor for
interleukin 10 is related to interferon
receptors. Proc Natl Acad Sci
USA 1993; 90: 11267±71.
13 Kotenko SV, Krause CD, Izotova LS,
Pollack BP,Wu W, Pestka S. Identification
and functional characterization
of a second chain of the interleukin-10
receptor complex.
EMBO J 1997; 16: 5894±903.
14 Kotenko SV, Pestka S. Jak±Stat signal
transduction pathway through
the eyes of cytokine class II receptor
complexes. Oncogene 2000; 19:
2557±65.
15 Reineke U, Sabat R,Volk HD,
Schneider-Mergener J. Mapping of
the interleukin-10/interleukin-10
receptor combining site. Protein Sci
1998; 7: 951±60.
16 Reineke U, Schneider-Mergener J,
Glaser RW, et al. Evidence for conformationally
different states of interleukin-10:
binding of a neutralizing
antibody enhances accessibility of a
hidden epitope. J Mol Recognit 1999;
12: 242±8.
17 Finbloom DS,Winestock KD. IL-10
induces the tyrosine phosphorylation
of tyk2 and Jak1 and the differential
assembly of STAT1 a and
STAT3 complexes in human T cells
and monocytes. J Immunol 1995; 155:
1079±90.
18 Carson WE, Lindemann MJ, Baiocchi
R, et al. The functional characterization
of interleukin-10 receptor expression
on human natural killer cells.
Blood 1995; 85: 3577±85.
19 Jurlander J, Lai CF, Tan J, et al. Characterization
of interleukin-10 receptor
expression on B-cell chronic lymphocy-